Form D · Biotechnology
BIOVEST INTERNATIONAL INC
Tampa, FL · CIK 0000704384
Offering snapshot reported Oct 29, 2010 · SEC filing
- Reported sold
- $7M Offering amount: $7M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Oct 19, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 29, 2010 | Initial | $7,000,000 | No comparison | 12 | SEC filing |
| Jan 30, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 30, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 22, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 19, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 9, 2006 | Paper | Not reported | No comparison | Not reported | |
| Apr 13, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $425K
- Finders' fees
- $0
- Form D file number
- 021-149797
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Roth Capital Partners, LLC | None |
Source: Form D, filed Oct 29, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christopher C Chapman | Director |
| Samuel S Duffey | Executive |
| Edmund J King | Director |
| Raphael J Mannino | Director |
| David D Moser | Executive |
| Francis E O'donnell | Director, Executive |
| Ronald E Osman | Director |
| Peter J Pappas | Director |
| Alan M Pearce | Executive |
| Jeffrey A Scott | Director |
| John Sitilides | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
324 S Hyde Park Ave Suite 350
Tampa, FL, 33606
Tampa, FL, 33606